Genomic Health Inc. (GHDX)

71.49
0.23 0.32
NASDAQ : Health Technology
Prev Close 71.72
Open 71.49
Day Low/High 69.69 / 72.07
52 Wk Low/High 50.77 / 92.18
Volume 331.23K
Avg Volume 676.90K
Exchange NASDAQ
Shares Outstanding 37.29M
Market Cap 2.71B
EPS 0.70
P/E Ratio 54.76
Div & Yield N.A. (N.A)
Genomic Health Reaches New 52-Week High (GHDX)

Genomic Health Reaches New 52-Week High (GHDX)

Genomic Health (Nasdaq:GHDX) hit a new 52-week high Friday as it is currently trading at $28.11, above its previous 52-week high of $27.99 with 29,034 shares traded as of 11:06 a.m. ET. Average volume has been 98,600 shares over the past 30 days.

Insiders Trading TSLA, GOOG, GHDX, MDVN

Insiders Trading TSLA, GOOG, GHDX, MDVN

The top 10 open-market insider purchases and sales filed at the SEC Thursday.

5 Stocks With Big Insider Buying

5 Stocks With Big Insider Buying

Insiders at these companies have been scooping up shares of their own stock lately.

Insiders Trading GHDX, CRR, CINF, MDAS

Insiders Trading GHDX, CRR, CINF, MDAS

The top 10 open-market insider purchases and sales filed at the SEC Wednesday.

Genomic Health Stock Hits New 52-Week High (GHDX)

Genomic Health Stock Hits New 52-Week High (GHDX)

Genomic Health (Nasdaq:GHDX) hit a new 52-week high Monday as it changed hands at $26.62 compared with its previous 52-week high of $26.53. Genomic Health is currently trading at $26.56 with 8,556 shares changing hands as of 9:36 a.m.

Insiders Trading CHK, AMZN, GHDX, IBOC

Insiders Trading CHK, AMZN, GHDX, IBOC

The top 10 open-market insider purchases and sales filed at the SEC Tuesday.

Insiders Trading IACI, GHDX, NBL

Insiders Trading IACI, GHDX, NBL

The top 10 open-market insider purchases and sales filed at the SEC Friday.

Genomic Health Stock Hits New 52-Week High (GHDX)

Genomic Health Stock Hits New 52-Week High (GHDX)

Genomic Health (Nasdaq:GHDX) hit a new 52-week high Friday as it changed hands at $23.74 compared with its previous 52-week high of $23.72. Genomic Health is currently trading at $23.74 with 16,120 shares changing hands as of 10:51 a.m..

Genomic Health Inc. Stock Downgraded By TheStreet Ratings (GHDX)

Genomic Health Inc. Stock Downgraded By TheStreet Ratings (GHDX)

Genomic Health (Nasdaq:GHDX) has been downgraded by TheStreet Ratings from from a buy to hold.

CVS Deal Could Be Nice 'Tuck-In': Analyst

CVS Deal Could Be Nice 'Tuck-In': Analyst

CVS Caremark's integration of Universal American's Medicare's Medicare Part D business could work well as long as CVS doesn't repeat its past mistakes.

Genomic Health - Upgrades & Downgrades

Genomic Health - Upgrades & Downgrades

TheStreet Ratings released rating changes on nine U.S. common stocks for December 16, 2010. Seven stocks were upgraded and two stocks were downgraded by our stock model.

BHR Buys $4.3M Worth of Six Flags Shares

BHR Capital buys 125,000 shares of Six Flags Entertainment worth $4.3 million.

Akamai Director Buys $2M Worth

Akamai Technologies Director Peter Kight buys 47,950 shares worth $2 million.

IPI Insiders Sell $36.75M in Shares

Intrepid Potash board members Robert Jornayvaz and Harvey Hugh each sell 750,000 shares of company stock.

Stock Offerings: AdCare Health

Stock Offerings: AdCare Health

AdCare Health prices an offering of approximately 1.71 million common shares at $3.50 per share

Baker Brothers Buys $2.3M Worth of Genomic

Baker Brothers Buys $2.3M Worth of Genomic

Baker Brothers Life Sciences Capital buys 132,070 shares of Genomic Health.

Baker Brothers Buys $5.8M Worth of Genomic Health

Baker Brothers buys 341,854 shares of GHDX.

Insider Buys $5M Worth of Americredit

Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.

Genomic Health Shares Rise On Analyst Upgrade

Genomic Health Shares Rise On Analyst Upgrade

Genomic Health shares gain ground, as Thomas Weisel analyst upgrades stock on value, outlook

Valueact Buys $31.5M Worth of Valeant

Valueact Buys $31.5M Worth of Valeant

Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.

Earnings Roundup: Garmin, Marsh & McLennan

Earnings roundup: Garmin profit shrinks by two-thirds, Marsh & McLennan posts 1Q profit

Genomic Health Shares Fall, 1st Qtr Meets Forecast

Genomic Health Shares Fall, 1st Qtr Meets Forecast

Genomic Health shares dip despite 1st-quarter results meeting Wall Street forecasts

Tuesday's Health Winners & Losers

Tuesday's Health Winners & Losers

Bentley Pharmaceuticals rises on a restructuring.

Wednesday's Small-Cap Winners & Losers

Wednesday's Small-Cap Winners & Losers

Shares of Wellco Enterprises soar on news of a buyout.

Today's Small-Cap Winners & Losers

Today's Small-Cap Winners & Losers

Innodata signs $9 milion worth of service contracts.

Wednesday's Health Winners & Losers

Wednesday's Health Winners & Losers

Genomic Health jumps.

UnitedHealth Deal Boosts Genomic Health

It will cover use of a breast cancer test.

Genomic Health Gets Aetna Pact

The sides reach a deal on payment rates.

Wednesday's Health Winners & Losers

Wednesday's Health Winners & Losers

Genomic Health is higher, but Prana Biotechnology drops.

Today's Health Winners and Losers

Today's Health Winners and Losers

Genomic Health shares get hammered after a downgrade.

TheStreet Quant Rating: B+ (Buy)